 NEW YORK, Dec. 29, 2020 PRNewswire -- Actinium Pharmaceuticals, Inc. NYSE AMERICAN: ATNM Actinium or the Company today announced that the independent Data Monitoring Committee DMC has completed the single ad hoc interim analysis of the pivotal Phase 3 SIERRA study of Iomab-B... 